Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy

Shaheer Khan, Jose Lutzky, Alexander N. Shoushtari, Joanne Jeter, Brian Marr, Thomas E. Olencki, Colleen M. Cebulla, Mohamed Abdel-Rahman, J. William Harbour, Naomi Sender, Alexandra Nesson, Shahnaz Singh-Kandah, Susana Hernandez, Jeanelle King, Manpreet S. Katari, Lyssa Dimapanat, Stephanie Izard, Grazia Ambrosini, Oliver Surriga, Alex J. RaiCodruta Chiuzan, Gary K. Schwartz, Richard D. Carvajal

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences